XBIOTECH INC. Current Assets
XBIOTECH INC. (XBIT) had Current Assets of $111.16 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $111.16M.
- 2026-03-31: Assets, Current $117.05M.
- 2025-12-31: Assets, Current $126.95M.
- 2025-09-30: Assets, Current $148.95M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $111.16M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $117.05M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $126.95M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $148.95M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $154.89M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $157.69M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $174.57M 10-K · filed 2026-03-13 |
| 2024-09-30 | $185.03M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $190.64M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $203.06M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $201.72M 10-K · filed 2025-03-18 |
| 2023-09-30 | $204.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $209.51M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $216.28M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $219.84M 10-K · filed 2024-03-15 |
| 2022-09-30 | $223.43M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $238.76M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $242.98M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $246.87M 10-K · filed 2023-03-15 |
| 2021-09-30 | $250.24M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $324.86M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $327.90M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $325.88M 10-K · filed 2022-03-15 |
| 2020-09-30 | $251.69M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $258.39M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $257.90M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $716.26M 10-K · filed 2021-03-16 |
| 2019-09-30 | $40.91M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $45.60M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $12.98M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $17.02M 10-K · filed 2020-03-16 |
| 2018-09-30 | $21.31M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $25.77M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $29.75M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $33.33M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $40.29M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $47.30M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $57.09M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $36.93M 10-K · filed 2018-03-16 |
| 2016-09-30 | $48.84M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $66.33M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $79.84M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $93.04M 10-K · filed 2017-03-16 |
| 2015-09-30 | $107.59M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $120.35M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $53.77M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $58.06M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |